The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 08, 2026

Filed:

Oct. 01, 2020
Applicants:

The Trustees of the University of Pennsylvania, Philadelphia, PA (US);

Dana-farber Cancer Institute, Inc., Boston, MA (US);

Inventors:

Amos B. Smith, III, Merion, PA (US);

Althea Erica Gaffney, Alexandria, VA (US);

Joseph G. Sodroski, Medford, MA (US);

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 405/14 (2006.01); A61K 39/00 (2006.01); A61P 31/18 (2006.01); C07D 209/20 (2006.01); C07D 403/12 (2006.01); C07D 405/04 (2006.01);
U.S. Cl.
CPC ...
C07D 405/14 (2013.01); A61K 39/00 (2013.01); A61P 31/18 (2018.01); C07D 209/20 (2013.01); C07D 403/12 (2013.01); C07D 405/04 (2013.01);
Abstract

The present disclosure provides compounds of Formula (I) or pharmaceutically acceptable salts thereof: (I) wherein, R1 to R6 and X are defined herein. Also provided are pharmaceutical compositions comprising these compounds, methods for treating Human Immunodeficiency Virus (HIV-1) in a subject in need thereof using these compounds or pharmaceutical compositions, and methods for stabilizing the state-1 conformation of the HIV-1 envelope glycoproteins using these compounds or pharmaceutical compositions.


Find Patent Forward Citations

Loading…